Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.5 USD | +4.29% | +2.63% | +43.24% |
Apr. 29 | Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target | MT |
Apr. 03 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.24% | 308M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.01% | 22.18B | |
-16.67% | 21.2B | |
-9.30% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- XOMA Stock
- News XOMA Corporation
- XOMA Acquires Interest in Pain Management Medication Dsuvia for $8 Million